- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
NanoStem Cell, a division of NanoInk, officially launched a new Web page today (1), which is dedicated to providing information and insights on its revolutionary new advancements in stem cell science.
This announcement follows the formation of the NanoStem Cell Division in January 2009, which is focused on providing a highly reliable and renewable source of differentiated adult stem cells, through the application of proprietary nanopatterning, using NanoInk's Dip Pen Nanolithography® (DPN®) technology.
"By using DPN nanopatterning technology, it is now possible to tightly control stem cell differentiation, which involves keeping adult stem cells in an undifferentiated form or inducing differentiation to a homogenous population of a targeted primary cell type," said Haris Jamil, Vice
President of the NanoStem Cell Division. "As a result, we will be able to provide pharmaceutical and biotech companies with access to large and renewable sources of homogeneous populations of differentiated stem cells for drug discovery, drug development and high throughput screening."
In addition, the NanoStem Cell Division offers solutions to the problems that have limited the utility of adult stem cells in academic and pharmaceutical research. James M. Hussey, NanoInk CEO, commented, "Our technology will lead to faster and more efficient drug discovery and
development processes, and will represent a giant step toward delivering on the promise of regenerative medicine."
NanoInk, the NanoInk logo, Dip Pen Nanolithography and DPN are trademarks or registered trademarks of NanoInk, Inc.
NanoInk, Inc. is an emerging growth technology company specializing in
nanometer-scale manufacturing and applications development for the life
science and semiconductor industries. Using Dip Pen Nanolithography® (DPN®),
a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create nanoscale structures from a wide variety of materials. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 140 patents and applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign. For more information on products and services offered by NanoInk, Inc., see www.nanoink.net.
Dresner Corporate Services
Dresner Corporate Services
Copyright © NanoInkIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Simulations predict flat liquid May 21st, 2015
New chip makes testing for antibiotic-resistant bacteria faster, easier: Researchers at the University of Toronto design diagnostic chip to reduce testing time from days to one hour, allowing doctors to pick the right antibiotic the first time May 28th, 2015
Arrowhead to Present at Jefferies 2015 Healthcare Conference May 27th, 2015
Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies: If results are confirmed in humans, tumor cells could someday be diagnosed by MRI imaging and treated with tumor-specific IV injections; new NIH grant will fund future study May 27th, 2015